Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Comparison Tests01:13

Multiple Comparison Tests

4.5K
Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
4.5K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

658
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
658
Bonferroni Test01:10

Bonferroni Test

3.5K
The Bonferroni test is a statistical test named after Carlo Emilio Bonferroni, an Italian mathematician best known for Bonferroni inequalities. This statistical test is a type of multiple comparison test to determine which means are different than the rest. Bonferroni test can minimize the Type 1 error by reducing the significance level alpha, which otherwise increases with sample pairs.
The means of different samples are first paired in all possible combinations.
The null hypothesis of the...
3.5K
¹H NMR Signal Multiplicity: Splitting Patterns01:13

¹H NMR Signal Multiplicity: Splitting Patterns

7.0K
When protons A and X are coupled, their nuclear spin energy levels are slightly modified. This is because the energy required to excite proton A to a spin state parallel to proton X is slightly different from the energy required for it to become anti-parallel to spin X. Consequently, there are two possible excitation frequencies for A (A1 and A2), depending on the spin state of X, and vice versa. The mutual nature of coupling implies that the difference between frequencies A1 and A2, indicated...
7.0K
Probability Laws01:49

Probability Laws

44.6K
Overview
44.6K
Test for Homogeneity01:23

Test for Homogeneity

2.5K
The goodness–of–fit test can be used to decide whether a population fits a given distribution, but it will not suffice to decide whether two populations follow the same unknown distribution. A different test, called the test for homogeneity, can be used to conclude whether two populations have the same distribution. To calculate the test statistic for a test for homogeneity, follow the same procedure as with the test of independence. The hypotheses for the test for homogeneity can...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Handling Missing Data in Participants with Baseline but No Post-Baseline Data.

Pharmaceutical statistics·2026
Same author

Comparative effectiveness of tirzepatide and semaglutide for obesity management in US clinical practice: a 6-month retrospective cohort study.

Journal of endocrinological investigation·2026
Same author

Overview and Practical Recommendations on Using Shapley Values for Identifying Predictive Biomarkers via CATE Modeling.

Statistics in medicine·2026
Same author

Next-Generation Sequencing-Based Testing Among Patients With Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer in the United States: Predictive Modeling Using Machine Learning Methods.

JMIR cancer·2025
Same author

Double machine learning methods for estimating average treatment effects: a comparative study.

Journal of biopharmaceutical statistics·2025
Same author

Improving randomized controlled trial analysis via data-adaptive borrowing.

Biometrika·2025
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Feb 25, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K

Multiplicity considerations in subgroup analysis.

Alex Dmitrienko1, Brian Millen2, Ilya Lipkovich3

  • 1Mediana, Inc., Overland Park, KS, U.S.A.

Statistics in Medicine
|August 2, 2017
PubMed
Summary
This summary is machine-generated.

This study addresses subgroup analysis in late-stage clinical trials, focusing on multiplicity issues. It provides methods for exploratory and confirmatory subgroup analyses to ensure consistent interpretation and labeling across patient populations.

Keywords:
clinical trialsconfirmatory subgroup analysisexploratory subgroup analysisinfluence and interaction conditionsmultiplicity adjustment

More Related Videos

Evaluation of Synaptic Multiplicity Using Whole-cell Patch-clamp Electrophysiology
10:52

Evaluation of Synaptic Multiplicity Using Whole-cell Patch-clamp Electrophysiology

Published on: April 23, 2019

13.8K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

17.4K

Related Experiment Videos

Last Updated: Feb 25, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K
Evaluation of Synaptic Multiplicity Using Whole-cell Patch-clamp Electrophysiology
10:52

Evaluation of Synaptic Multiplicity Using Whole-cell Patch-clamp Electrophysiology

Published on: April 23, 2019

13.8K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

17.4K

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Pharmaceutical Research

Background:

  • Subgroup analysis is crucial in late-stage clinical trials for identifying treatment effects in specific patient groups.
  • Multiplicity issues, arising from multiple comparisons, can inflate Type I error rates and lead to false positive findings.

Purpose of the Study:

  • To provide a comprehensive overview of multiplicity considerations in subgroup analysis within clinical trials.
  • To outline principled approaches for exploratory and confirmatory subgroup analyses.
  • To offer guidelines for interpreting findings and ensuring consistent labeling across patient populations.

Main Methods:

  • Review of multiplicity issues in exploratory subgroup analysis.
  • Discussion of principled subgroup search strategies for biomarker-driven designs.
  • Survey of multiplicity adjustment methods for confirmatory subgroup analysis in multi-population trials.

Main Results:

  • Identification of key challenges in subgroup analysis, particularly concerning multiplicity.
  • Presentation of methods for both exploratory and confirmatory subgroup investigations.
  • Introduction of guidelines for interpreting significant subgroup findings.

Conclusions:

  • Effective management of multiplicity is essential for valid subgroup analysis in clinical trials.
  • Pre-specified subgroup analyses and appropriate statistical adjustments enhance reliability.
  • Clear interpretation guidelines aid decision-making and support consistent drug labeling.